GENETIC TECHNOLOGIES LIMITED — Board/Management Information 2003

May 5, 2003

May $6^{th}$ , 2003

The Manager Company Announcements Office Australian Stock Exchange Limited Exchange Centre 20 Bridge Street Sydney NSW 2000

Dear Sir.

Appointment of Russell Granzow to the Board of Directors

Genetic Technologies Limited ("GTG") is pleased to announce that Mr. Russell Granzow, of Princeton, New Jersey, USA, has been invited to join the Board of GTG as an Executive Director.

Mr. Granzow is well-known in the US as a founder of Orchid Bioscience, and until recently, he served as its Vice President of Strategic Planning and Business Development.

Mr. Granzow received his early training in biotechnology at University of Illinois, and initially worked with Schering-Plough Corp, Pharmacia Biosensor and Sarnoff. It was while at Sarnoff that genomics and micro-fluidics research led to the spin-off of Orchid Bioscience in 1997.

At Orchid, Mr. Granzow managed 4 successful acquisitions, played a key role in Orchid's listing on NASDAO in 2000 and developed their licensing program, which saw revenues grow from zero to \$65M in 4 years. Overall, Mr. Granzow directed some 40 separate deals relating to genomics, collaborative research and licensing.

Mr. Granzow has also published 7 scientific papers, is inventor of two issued patents and has presented at numerous scientific and business meetings world-wide.

With the appointment of Mr. Granzow to the Board of GTG, the Board now comprises 5 Directors, 3 of whom come from the world of biotechnology.

Mr Granzow will be based in the USA and his initial responsibilities will focus primarily on the licensing of the GTG non-coding patents in USA and Europe.

Yours faithfully,

Dr Mervyn Jacobson Executive Chairman